Drug licences of 9 pharma dealers suspended in Jammu

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, the official said

Jammu:  Authorities here on Saturday suspended drug sale licences of nine dealers in a special drive carried out to curb misuse of pharmaceuticals with habit forming ingredients, an official said.

The drive was conducted by the J-K Drugs and Food Control Organisation to identify and take punitive action against “unscrupulous elements dealing with such drugs in a clandestine manner,” an official spokesperson said.

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, he said.

The ingredient was being sourced directly from the suppliers based outside Jammu and Kashmir illegally, he said.

More scrutiny revealed that the firms procured and distributed these medicinal preparations without maintaining the sales records as mandated under the Drugs & Cosmetics Act, 1940, the spokesperson said. S

Stocks of pharmaceutical preparations, which are prone to addiction, worth over Rs 13.58 lakh were also seized, he said.

J-K State Drugs Controller Lotika Khajuria warned against indulging in procuring lesser-known brands of drugs formulations consisting of habit forming ingredients directly from the suppliers, or manufacturers located outside J-K.

“In case any violation is reported, the defaulters shall be dealt strictly in accordance with zero-tolerance policy adopted by the government against persons involved in promoting drug abuse which warrants the cancellation of such licences as also legal mandate,” she said.

Related Posts

UP expands food, drug testing capacity across all 18 divisions

Commissioner FSDA Roshan Jacob said recruitment of 357 Junior Analysts (Drug) had been completed, while selection for 457 Junior Analyst (Food) posts was underway to address the shortage of technical…

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott, the global healthcare leader, announced it received US Food and Drug Administration (FDA) approval and CE Mark for the UltiSynq defibrillation lead, which is designed to deliver both conduction…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

UP expands food, drug testing capacity across all 18 divisions

UP expands food, drug testing capacity across all 18 divisions

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel

Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel

Pakistan handlers behind drug, arms supply network busted in Mohali; four arrested

Pakistan handlers behind drug, arms supply network busted in Mohali; four arrested

Survival of a Boy from Krait Snake Bite! Unheard & Unwonted!!

Survival of a Boy from Krait Snake Bite! Unheard & Unwonted!!